The White House budget proposal for fiscal 2014 contains some new items related to biopharmaceuticals compared to years past, including increasing the discount for brand drugs used by Medicare Part D enrollees in the donut hole to 75% and reducing the Medicare Part B drug reimbursement rate to average sales price plus 3%.
HHS’ proposed overall budget for 2014 would be $80.1 billion, an increase of $3.9 billion over the enacted appropriation for...